220 related articles for article (PubMed ID: 29084921)
1. Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy.
Zeng Q; Liu J; Cao P; Li J; Liu X; Fan X; Liu L; Cheng Y; Xiong W; Li J; Bo H; Zhu Y; Yang F; Hu J; Zhou M; Zhou Y; Zou Q; Zhou J; Cao K
Clin Cancer Res; 2018 Jan; 24(2):445-459. PubMed ID: 29084921
[No Abstract] [Full Text] [Related]
2. The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway.
Zhou Y; Chu X; Deng F; Tong L; Tong G; Yi Y; Liu J; Tang J; Tang Y; Xia Y; Dai Y
Oncotarget; 2017 Jul; 8(30):48755-48768. PubMed ID: 28548944
[TBL] [Abstract][Full Text] [Related]
3. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y
J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374
[TBL] [Abstract][Full Text] [Related]
4. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
[TBL] [Abstract][Full Text] [Related]
6. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
Xu ST; Ding X; Ni QF; Jin SJ
Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
[TBL] [Abstract][Full Text] [Related]
7. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
[TBL] [Abstract][Full Text] [Related]
8. High PRMT5 expression is associated with poor overall survival and tumor progression in bladder cancer.
Tan L; Xiao K; Ye Y; Liang H; Chen M; Luo J; Qin Z
Aging (Albany NY); 2020 May; 12(9):8728-8741. PubMed ID: 32392182
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel inhibits the progression of cervical cancer by inhibiting autophagy via lncRNARP11-381N20.2.
Zou SH; Du X; Lin H; Wang PC; Li M
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3010-3017. PubMed ID: 29863245
[TBL] [Abstract][Full Text] [Related]
10. SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival.
Liu JY; Zeng QH; Cao PG; Xie D; Yang F; He LY; Dai YB; Li JJ; Liu XM; Zeng HL; Fan XJ; Liu L; Zhu YX; Gong L; Cheng Y; Zhou JD; Hu J; Bo H; Xu ZZ; Cao K
Oncogene; 2018 Jul; 37(29):3937-3952. PubMed ID: 29662193
[TBL] [Abstract][Full Text] [Related]
11. Overexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissues.
Jiang YQ; Zhong TF; Dang YW; Zou LS; Yang L; Yang X; Chen G
Asian Pac J Cancer Prev; 2014; 15(21):9137-42. PubMed ID: 25422191
[TBL] [Abstract][Full Text] [Related]
12. Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer.
Li YP; Zhu JF; Huang KT; Wang RR; Cai B; Xie H; Chen HD
Chin Med J (Engl); 2018 Jan; 131(2):188-193. PubMed ID: 29336367
[TBL] [Abstract][Full Text] [Related]
13. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
[TBL] [Abstract][Full Text] [Related]
14. Anti-Cancer Effects of Radix Angelica Sinensis (Danggui) and N-Butylidenephthalide on Gastric Cancer: Implications for REDD1 Activation and mTOR Inhibition.
Liao KF; Chiu TL; Huang SY; Hsieh TF; Chang SF; Ruan JW; Chen SP; Pang CY; Chiu SC
Cell Physiol Biochem; 2018; 48(6):2231-2246. PubMed ID: 30114701
[TBL] [Abstract][Full Text] [Related]
15. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
[TBL] [Abstract][Full Text] [Related]
17. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Cellular Proliferation and Invasion by HMGB1 Knockdown in Bladder Urothelial Carcinoma Cells.
Liao H; Xiao Y; Hu Y; Xiao Y; Yin Z; Liu L
Oncol Res; 2014; 22(5-6):235-45. PubMed ID: 26629935
[TBL] [Abstract][Full Text] [Related]
19. The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells.
Pang K; Zhang Z; Hao L; Shi Z; Chen B; Zang G; Dong Y; Li R; Liu Y; Wang J; Zhang J; Cai L; Han X; Han C
BMC Cancer; 2019 Mar; 19(1):225. PubMed ID: 30866868
[TBL] [Abstract][Full Text] [Related]
20. Autophagy inhibition enhances RAD001-induced cytotoxicity in human bladder cancer cells.
Lin JF; Lin YC; Yang SC; Tsai TF; Chen HE; Chou KY; Hwang TI
Drug Des Devel Ther; 2016; 10():1501-13. PubMed ID: 27143856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
